Story Tag: Pegfilgrastim Biosimilars Market 2022
Global Pegfilgrastim Biosimilars Market is All Set to Break $4,037.1 million Barrier in 2030 newstrail.com
According to a report by Altus Market Research titled, “Pegfilgrastim Biosimilars Global Market 2022 Opportunities And Strategies To 2030: By Application: (Chemotherapy Induced Neutropenia; Transplantation; Others); By Distribution Channel: (Hospital Pharmacies; Retail Pharmacies; Mail-Order Pharmacies)”, the global pegfilgrastim biosimilars market reached a value of nearly $902.1 million in 2020. The market is expected to grow from $902.1 million in 2020 to $1,801.0 million in 2025…